Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign ...
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.515
https://www.valueinhealthjournal.com/article/S1098-3015(17)30849-5/fulltext
Title :
Estimating The Economic Benefit Of Treatment With Alpha-Blocker Plus Antimuscarinic As A Fixed-Dose Combination (FDC) Tablet Versus Concomitant Combination Therapy (CCT) In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30849-5&doi=10.1016/j.jval.2017.08.515
First page :
A489
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
482